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Introduction  
• Approx. 300,000 heart valve replacements are 
performed annually; however, current treatment 
options have limited success, especially for 
paediatric patients. 
 
• Current therapies cannot grow or remodel with the 
patient. These shortcomings have prompted 
increased focus on tissue engineering techniques to 
create fully autologous heart valve replacements.  
 
• Despite significant advances in the field of heart 
valve tissue engineering, a major problem is the 
inability of valves to maintain an appropriate seal 
upon closure as a result of cell-mediated retraction 
of the leaflets [1].  
 
• We are currently investigating natural biomaterials 
(collagen, glycosaminoglycans (GAGs) and fibrin) 
for the development of a scaffold which will have 
sufficient stiffness to resist the contractile forces of 
cells acting upon it. 
 
• The novel scaffold proposed is based around the 
concept of reinforcing a cell-seeded fibrin gel 
component [2] with a collagen-GAG (CG) matrix.  
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On-going Investigation 
Figure 4. Masson’s 
trichrome staining of a 
leaflet section of 3-D CG 
(blue) with fibrin (red) 
showing that the fibrin 
has completely 
permeated the 3-D CG 
material.  
• This study has led to the development of a freeze-dried 
3-D CG-fibrin scaffold which will be further investigated 
for heart valve tissue engineering.  
 
• This freeze-dried 3-D CG scaffold has a homogeneous 
pore structure throughout and can be manufactured in a 
repeatable, 3-D form.  
 
• A 0.75% collagen and 0.05% GAG concentration ratio, 
has been identified as the most stable crosslinked  
material  to work with.  
 
• Crosslinking CG using DHT and an EDAC:NHS solution 
in ethanol has been found to produce a repeatable 
material with excellent handling characteristics and a 
stiffness both in tension and compression greater than 
un-crosslinked CG (data not shown).  
 
• Fibrin has been shown to have been infiltrated 
successfully through the 3-D CG material using an 
injection method together with a support structure. 
 
• Mechanical testing of the 3-D CG-fibrin material 
demonstrated a compressive  modulus of approx. 3kPa 
for both the cuff and the leaflet areas. 
• Hypothesis: A CG-fibrin scaffold will provide sufficient 
structural stiffness to resist the contractile forces of 
cells.  
 
• Aim of this study: To develop a method of fabricating 
the CG-fibrin scaffold in a heart valve shape and 
optimise the resulting material using different 
concentrations and crosslinking methods for  
improved mechanical properties.  
Figure 2. This image 
shows the 3-D CG freeze-
dried material. Through 
optimisation of the freeze 
drying process, a  tri-
leaflet valve was 
fabricated.  
• Freeze drying parameters such as final freezing 
temperature, cooling rate and drying times were 
optimised to produce a CG scaffold with a homogenous 
pore size structure [5]. 
 
• The freeze drying cycle optimisation was assessed 
using SEM, pore size and porosity analysis. 
 
• Scaffolds were crosslinked physically by 
dehydrothermal (DHT) cross-linking at 105ºC for 24 
hours.  
 
• A protocol was developed for chemical crosslinking 
using 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide 
(EDAC) in the presence of N-hydroxysuccinimide 
(NHS), solution which stiffens the scaffold while 
maintaining elasticity [6]. The difference to previous 
work was that the material was crosslinked in the 
presence of ethanol. 
 
• Different concentrations of both collagen and GAG 
were freeze dried in the 3-D mould to find the most 
stable concentration post-crosslinking for infiltration 
with fibrin. 
 
• To infiltrate the 3-D CG material with fibrin (a four-
component solution which polymerises once the final 
ingredient is added), both drop loading and injection 
methods were assessed and a support structure was 
designed and built.  
 
• Masson’s trichrome staining and scanning electron 
microscopy (SEM) were used to assess the distribution 
of the fibrin throughout the CG material. Cryosectioning 
was used to preserve the morphology of the materials. 
 
• Mechanical properties were tested using a Zwick/Roell 
Z050 testing machine. 
Materials & Methods 
Figure 1. We have 
previously developed a 
mould for the 
construction of tri-
leaflet heart valve 
conduits [1,3,4] This 
mould was modified for 
producing freeze-dried 
CG scaffolds. 
• We successfully developed a freeze-dried CG 
material with a homogenous structure in a tri-leaflet 
valve conduit shape.  
• We successfully developed a method of infiltrating 
the 3-D CG material with fibrin using an injection 
technique and a support structure. Injection of the 
fibrin solution allowed for an even distribution of 
polymerised fibrin throughout the material as 
demonstrated in Figure 5.   
• The next phase of this study is to introduce cells to the 
material in order to assess its biological performance. 
This will also demonstrate the resistance of the 
material to the contractile forces exerted by the cells.  
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INVESTIGATION OF A NEW MATERIAL FOR HEART VALVE TISSUE ENGINEERING 
• A  3-D CG scaffold was fabricated through freeze 
drying in a custom-built mould (Figure 1). 
Figure 5. SEM image of 
freeze-dried CG (B), 
infiltrated with fibrin (A) 
using an injection 
method.  Image shows 
infiltration of fibrin 
through the CG structure. 
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Figure 6. This image 
shows a sample of the 
3-D CG material, post 
crosslinking and post 
infiltration with fibrin. 
The material stands up 
under its own weight 
and is easy to handle.  
• Freeze drying using a concentration of 0.75% 
collagen and 0.05% GAG demonstrated the best 
infiltration of fibrin and had the optimum handling 
characteristics post-crosslinking (see Figure 6). 
These concentrations also exhibited the highest 
compressive modulus from all samples. 
Figure 3. The image here 
shows the pore structure 
of a section of the leaflet 
from the 3-D CG freeze 
dried material. The 
average pore size 
(~100um) was 
homogenous between the 
leaflet and the cuffs of the 
material. Porosity of  
approx. 85% was 
measured in the material. 
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• There were no statistically significant differences in the 
compressive moduli between the 3-D CG-fibrin cuff and 
leaflet, as shown in Figure 7. This suggests we have 
produced a material with homogenous stiffness 
characteristics. 
Figure 7. With no statistical difference between the 
compressive moduli of the leaflet versus the cuff, the material 
appears homogenous and ready to be examined when cells 
are introduced with the fibrin acting as the cell delivery matrix.   
